Back to top

Image: Bigstock

Compared to Estimates, Adient (ADNT) Q2 Earnings: A Look at Key Metrics

Read MoreHide Full Article

For the quarter ended March 2026, Adient (ADNT - Free Report) reported revenue of $3.87 billion, up 7% over the same period last year. EPS came in at $0.52, compared to $0.69 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $3.57 billion, representing a surprise of +8.29%. The company delivered an EPS surprise of +41.38%, with the consensus EPS estimate being $0.37.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Adient performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Light Vehicle Production - Global: 21.5 million versus the two-analyst average estimate of 21.21 million.
  • Light Vehicle Production - North America: 3.7 million compared to the 3.71 million average estimate based on two analysts.
  • Light Vehicle Production - Asia, excluding China, and Other: 6 million compared to the 5.75 million average estimate based on two analysts.
  • Light Vehicle Production - EMEA: 4.6 million versus 4.33 million estimated by two analysts on average.
  • Light Vehicle Production - China: 6.5 million versus the two-analyst average estimate of 6.47 million.
  • Light Vehicle Production - South America: 0.7 million versus the two-analyst average estimate of 0.7 million.
  • Net Sales- Americas: $1.88 billion compared to the $1.66 billion average estimate based on three analysts. The reported number represents a change of +10.9% year over year.
  • Net Sales- Eliminations: $-25 million versus the three-analyst average estimate of $-24.78 million. The reported number represents a year-over-year change of -3.9%.
  • Net Sales- Asia: $734 million compared to the $696.9 million average estimate based on three analysts. The reported number represents a change of +3.8% year over year.
  • Net Sales- EMEA: $1.27 billion versus $1.23 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +3.3% change.

View all Key Company Metrics for Adient here>>>

Shares of Adient have returned +7.6% over the past month versus the Zacks S&P 500 composite's +11.4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Zacks' 7 Best Strong Buy Stocks (New Research Report)

Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.

Click Here, It's Really Free

Published in